Close
Close

M.D. Anderson Cancer Center - Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System

Partner

Not provided

Rare Disease

Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System

Sponsor

M.D. Anderson Cancer Center

Access Program Information

The goal of this clinical research study is to use 68GA-DOTATOC instead of the standard-of-care 111-In-pentetreotide as a tracer chemical during PET/CT scans for diagnosing neuroendocrine tumors. A tracer is injected into participant's bloodstream to help the study doctor see possible tumors.

Contact

Contact: (713-563-3687)

Locations
  • United States
  • Houston, Texas, United States

Free Newsletter